Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection
Clinical trial NCT03880539 · COMPLETED
Trial details
- NCT number
- NCT03880539
- Sponsor
- University of Kansas Medical Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-25
- Primary completion
- 2021-11-18
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.